Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure

Annals of Surgery

Volumn 236, Issue 2, 2002, Pages 254-260

  Rumalla, Vishnu K ^a   Calvano, Steve E ^a   Spotnitz, Alan J ^a   Krause, Tyrone J ^a   Hilkert, Robert J ^a   Lin, Edward ^a   Lowry, Stephen F ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART LEFT VENTRICLE COMPLIANCE; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK BENEFIT ANALYSIS;

AGED; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; CYTOKINES; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0036323317     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200208000-00015     Document Type: Article

References (36)

1. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults
2. Mediators of inflammation and injury
3. Tumor necrosis factor is expressed in cardiac tissues of patients with heart failure
4. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart
5. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD)
6. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
7. Septic myocardial dysfunction: Role of cytokines and nitric oxide
8. Biologic control of injury and inflammation: Much more than too little
9. Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans
10. The influence of human endotoxemia on CD 95-induced apoptosis
11. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis
12. Circulating mediators in serum of injurd patients with septic complication inhibit neutrophil apoptosis through upregulation of protein-tyrosine phosphorylation
13. Granulocyte apoptosis and the control of inflammation
14. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
15. Plasma Fas ligand, and inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure
16. Detection of circulating tumor necrosis factor after endotoxin administration
17. Plasma tumor necrosis factor in patients with septic shock: Mortality rate, incidence of adult respiratory distress syndrome and effects of methylprednisolone administration
18. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease
19. Shock and tissue injury induced by recombinant human cachectin
20. The role of cytokine mediators in septic shock
21. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingo-lipid signaling cascade in cardiac cell death
22. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction
23. Systemic inflammation in patients with heart failure
24. Cytokine profile in chronic cardiac failure
25. Human tumor necrosis factor alpha mutants with exclusive specificity for the 55 kDA or 75 kDA TNF receptors
26. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
27. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo
28. Safety and efficacy of a soluble p75 tumor necrosis factor receptor in patients with advanced heart failure
29. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
30. Cytokine inhibitors in patients with heart failure and impaired functional capacity
31. Tumor necrosis-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models
32. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
33. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
34. Captopril - A potential free radical scavenger: Inhibition of PMN NADPH oxidase
35. The cardiac glycoside digoxin does not alter the activity of human polymorphonuclear leukocytes in vitro